Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 473

1.

Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.

Adone R, Francia M, Pistoia C, Petrucci P, Pesciaroli M, Pasquali P.

Vaccine. 2012 Jun 8;30(27):3992-5. doi: 10.1016/j.vaccine.2012.04.009. Epub 2012 Apr 20.

PMID:
22521283
2.

Evaluation of Brucella melitensis B115 as rough-phenotype vaccine against B. melitensis and B. ovis infections.

Adone R, Francia M, Ciuchini F.

Vaccine. 2008 Sep 8;26(38):4913-7. doi: 10.1016/j.vaccine.2008.07.030. Epub 2008 Aug 15.

PMID:
18675869
3.

B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.

Adone R, Francia M, Pistoia C, Pesciaroli M, Pasquali P.

Vaccine. 2011 Mar 21;29(14):2523-9. doi: 10.1016/j.vaccine.2011.01.072. Epub 2011 Feb 5.

PMID:
21300102
4.

Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis.

Jiménez de Bagüés MP, Elzer PH, Jones SM, Blasco JM, Enright FM, Schurig GG, Winter AJ.

Infect Immun. 1994 Nov;62(11):4990-6.

5.

Antigenic, immunologic and genetic characterization of rough strains B. abortus RB51, B. melitensis B115 and B. melitensis B18.

Adone R, Muscillo M, La Rosa G, Francia M, Tarantino M.

PLoS One. 2011;6(10):e24073. doi: 10.1371/journal.pone.0024073. Epub 2011 Oct 31.

6.

Brucella melitensis B115-based complement fixation test to detect antibodies induced by Brucella rough strains.

Adone R, Francia M, Ciuchini F.

J Appl Microbiol. 2008 Aug;105(2):567-74. doi: 10.1111/j.1365-2672.2008.03787.x. Epub 2008 Mar 18.

7.

Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.

Vemulapalli R, Contreras A, Sanakkayala N, Sriranganathan N, Boyle SM, Schurig GG.

Vet Microbiol. 2004 Sep 8;102(3-4):237-45.

PMID:
15327798
8.

In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp.

Wang Z, Niu J, Wang S, Lv Y, Wu Q.

Clin Vaccine Immunol. 2013 Feb;20(2):174-80. doi: 10.1128/CVI.00573-12. Epub 2012 Dec 12.

9.

Protective properties of rifampin-resistant rough mutants of Brucella melitensis.

Adone R, Ciuchini F, Marianelli C, Tarantino M, Pistoia C, Marcon G, Petrucci P, Francia M, Riccardi G, Pasquali P.

Infect Immun. 2005 Jul;73(7):4198-204.

10.

Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes.

el Idrissi AH, Benkirane A, el Maadoudi M, Bouslikhane M, Berrada J, Zerouali A.

Rev Sci Tech. 2001 Dec;20(3):741-7.

PMID:
11732416
11.

Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.

Winter AJ, Schurig GG, Boyle SM, Sriranganathan N, Bevins JS, Enright FM, Elzer PH, Kopec JD.

Am J Vet Res. 1996 May;57(5):677-83.

PMID:
8723881
13.

Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.

Tadepalli G, Singh AK, Balakrishna K, Murali HS, Batra HV.

Mol Immunol. 2016 Mar;71:34-41. doi: 10.1016/j.molimm.2016.01.001. Epub 2016 Jan 27.

PMID:
26826463
14.

Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.

Grilló MJ, Manterola L, de Miguel MJ, Muñoz PM, Blasco JM, Moriyón I, López-Goñi I.

Vaccine. 2006 Apr 5;24(15):2910-6. Epub 2006 Jan 6.

PMID:
16439039
15.

Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.

Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.

Infect Immun. 2009 Jan;77(1):436-45. doi: 10.1128/IAI.01151-08. Epub 2008 Nov 3. Erratum in: Infect Immun. 2009 Apr;77(4):1719.. Samartino, Clara García [corrected to García Samartino, Clara].

16.
17.

Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice.

Surendran N, Sriranganathan N, Lawler H, Boyle SM, Hiltbold EM, Heid B, Zimmerman K, Witonsky SG.

Vaccine. 2011 Mar 24;29(15):2749-55. doi: 10.1016/j.vaccine.2011.01.090. Epub 2011 Feb 20.

PMID:
21316499
19.
20.

Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.

Kahl-McDonagh MM, Arenas-Gamboa AM, Ficht TA.

Infect Immun. 2007 Oct;75(10):4923-32. Epub 2007 Jul 30.

Supplemental Content

Support Center